[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

Marx, 1986 - Google Patents

The Slow, Insidious Natures of the HTLV's: The scope of the viruses that cause AIDS and certain leukemias and lymphomas is broadening in terms of number of …

Marx, 1986

Document ID
17154163893749453357
Author
Marx J
Publication year
Publication venue
Science

External Links

Snippet

Trois Ilets, Martinique. W HEN some 60 researchers gathered recently on the French island of Martinique for a meeting on" Viruses and Cancers,"* the program reflected the great interest that has been generated by the human T-cell lymphotropic viruses (HTLV's) …
Continue reading at www.science.org (other versions)

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/21—Interferons [IFN]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse Transcribing RNA Viruses
    • C12N2740/00011—Reverse Transcribing RNA Viruses
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, E.G. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS

Similar Documents

Publication Publication Date Title
Gill et al. Clinical effect of glucocorticoids on Kaposi sarcoma related to the acquired immunodeficiency syndrome (AIDS)
Pomerantz et al. Lipopolysaccharide is a potent monocyte/macrophage-specific stimulator of human immunodeficiency virus type 1 expression.
Finnegan et al. IL-10 cooperates with TNF-alpha to activate HIV-1 from latently and acutely infected cells of monocyte/macrophage lineage.
Bagasra et al. CD14 is involved in control of human immunodeficiency virus type 1 expression in latently infected cells by lipopolysaccharide.
GARTNER et al. Macrophage tropism of HIV-1
Rosenberg et al. Immunopathogenic mechanisms of HIV infection
Merigan et al. Short-course human leukocyte interferon in treatment of herpes zoster in patients with cancer
Petersen et al. Molluscum contagiosum in HIV-lnfected Patients
Marx The Slow, Insidious Natures of the HTLV's: The scope of the viruses that cause AIDS and certain leukemias and lymphomas is broadening in terms of number of people affected and range of clinical syndromes
Mitsuyasu Interferon alpha in the treatment of AIDS‐related Kaposi's sarcoma
KR19990044834A (en) Negative Factor Inhibitor
AU638693B2 (en) Treatment methods and vaccines
De Francesco et al. HIV p17 enhances lymphocyte proliferation and HIV-1 replication after binding to a human serum factor
Mikkelsen et al. Unbalanced X/autosomal translocation with inactivation of the normal X chromosome
Louie et al. Effects of interleukin-1 and interleukin-1 receptor antagonist in AIDS-Kaposi's sarcoma
AU641002B2 (en) Method of treatment of retrovirus infections
Okedoye et al. Mathematical analysis of affinity hemodialysis on t-cell depletion
JPS60155121A (en) Therapy for acquired immunological dysfunction syndrome
De Wit AIDS‐associated Kaposi'i sarcoma and the mechanisms of interferon alpha'a activity; a riddle within a puzzle
Warfel et al. Synergism between interferon-γ and cytokines or lipopolysaccharide in the activation of the HIV-LTR in macrophages
Dalgleish Kaposi's sarcoma.
Schuitemaker IL4 and IL10 as potent inhibitors of HIV1 replication in macrophages in vitro: a role for cytokines in the in vivo virus host range?
Gill Pathogenesis of HIV-related malignancies
JP2000505433A (en) Use of 3-amino-4-hydroxybenzoic acid for the treatment of retroviral infection
CA1292691C (en) Method for the effective treatment of disease conditions in humans associated with htl virus infection